Jack Allen1,2, Peter Gatehouse1,2, Rick Wage1, David Firmin1,2, and Jennifer Keegan1,2
1Cardiovascular Magnetic Resonance Unit, Royal Brompton and Harefield NHS Trust, London, United Kingdom, 2National Heart and Lung Institute, Imperial College London, London, United Kingdom
Synopsis
3D LGE is used to assess scar in patients with atrial
fibrillation. However, the fast and variable heart rate in these patients
results in poor image quality. An existing dynamic-TI method varies inversion
time on a beat-by-beat basis (according to the previous cardiac cycle length) to
improve myocardial nulling, but blood signal variations are incompletely
corrected and cause ghosting. We have developed an improved technique which
bases the beat-by-beat TI on the history
of RR intervals (rather than the previous one) and reduces blood signal
variations while maintaining myocardial nulling. Simulations with patient RR
interval distributions show significantly improved results.
Introduction
3D LGE
is a promising tool for assessing atrial scar distribution and burden in
patients with atrial fibrillation (AF). However, single R-wave gating (needed
to reduce study duration) coupled with the fast and variable heart rate in this
patient population results in reduced image quality with poor myocardial
nulling and ghosting.
Techniques
have been developed to improve image quality including saturation-inversion
recovery [1], dynamic flip angle [2] and dynamic inversion
time (dynamicTI) [3]. In the latter approach, the inversion time is
varied on a beat-by-beat basis to improve myocardial nulling, according to the
length of the previous cardiac cycle. However, variations in the blood pool
signal are incompletely corrected (due to its different T1) and ghosting is
still an issue.
In this
work, we develop a new dynamicTI technique which (i) bases the beat-by-beat TI
calculation on the history of RR
intervals (rather than just the previous one) and (ii) reduces the blood pool
signal variations through the acquisition (rather than the myocardial signal
variations) while maintaining the myocardial signal close to zero.Methods
Our proposed method uses the RR interval history up to any
given cardiac cycle to determine the TI for that cardiac cycle to achieve
consistent blood signal throughout the acquisition. To do this we use Bloch
simulations of the 3D inversion-prepared segmented gradient echo sequence (TR
3.5ms, views per cardiac cycle 37, flip angle 20, centric ky inside centric kz)
to model the longitudinal magnetisation (Mz) throughout the acquisition.
We developed a 3D numerical phantom of a left ventricular
short axis volume (blood T1 = 420ms, scar T1 = 360ms, myocardium T1 = 490ms)
and performed MATLAB simulations using (i) fixedTI (based on the average RR
interval through the acquisition), (ii) original dynamicTI [3] and
(iii) new dynamicTI using a patient-specific target Mz for blood. The target
blood Mz was based on the mean RR interval over the first 30 cardiac cycles and
is the blood Mz at the myocardium null time at that mean RR interval.
Simulations were performed using RR interval data from 43
patients with persistent AF who attended for 3D LGE prior to RF ablation and
from 14 patients post RF ablation. For each dataset, the standard deviation (SD)
of the RR intervals was used as a measure of RR interval variability.
For each simulation, mean myocardial (myo) signal, mean
ghosting signal, scar-blood contrast-to-ghosting ratio (CGR) and scar-myo CGR
were calculated. ANOVA and subsequent paired t-testing (with Bonferroni
correction) were used to assess statistical differences between the three
methods.Results
Figure 1 shows blood, myo and scar Mz for the most central
k-space line in each of 20 cardiac cycles in an example simulation. While the
original dynamicTI method aims to reduce the Mz variations of myo, Fig. 1
shows that the new method reduces the Mz variations of the blood pool with a
view to reducing blood pool ghosting.
Simulations using all three methods are shown in an example
post-ablation case in Fig. 2, together with the associated RR interval
histogram and the ghosting signal histograms. Both dynamicTI techniques improve myocardial nulling and reduce
ghosting compared to the fixedTI technique, with the ghosting level for the new
dynamicTI technique being less than that of the original dynamicTI
technique. This is more apparent in the
pre-ablation example in Fig. 3 where there were multiple missed cardiac triggers.
The results of the pre-ablation and post-ablation
simulations are shown in Table 1. Compared to fixedTI, both dynamic TI methods
improve scar-blood and scar-myo CGR and improve myocardial nulling. Comparing
the new and original dynamicTI methods, pre-ablation ghosting signal is
reduced (0.22 +/- 0.06 vs 0.18 +/- 0.03, p<0.0001) and both scar-blood CGR and
scar-myo CGR are improved (22.5 +/- 8.2 vs 26.2 +/- 6.8, p<0.001 and
40.2 +/- 14.9 vs 45.7 +/- 12.8, p<0.001 respectively). Myo signal nulling is maintained (0.17 +/- 0.04 vs 0.18 +/- 0.03, p=ns). Similar trends are shown in the
post-ablation simulations although these are less marked as the RR interval
variability is less than in the pre-ablation simulations (RR interval
variability: 158ms +/- 85ms vs 287ms +/- 80ms.).Discussion
Our new dynamic TI method, which targets a patient-specific
constant blood pool signal through the acquisition, significantly reduces
ghosting and improves both scar-blood and scar-myo CGR compared to the original
method which targets a constant myocardial signal. In future work the proposed approach will be integrated into
an imaging sequence, for phantom and in vivo validation.
A disadvantage of
our new technique (as with the original dynamicTI technique) is that it
targets a single T1 , allowing signal variations from different T1 materials to
persist. However, by targeting the T1 of blood (which is responsible for most of
the ghosting signal) rather than myocardium, the image improvement (in terms of
reduced ghosting and improved contrast) is greater. Compared to methods that
introduce partial [2] or full [1] saturation pulses, SNR is not inherently
reduced by our new method.Acknowledgements
This work was supported by the British Heart Foundation (BHF).References
1. Weingärtner et al. MRM, 71(3), 1024–1034. (2014)
2. Hu et al. JMRI, 49(3), 688–699. (2019).
3. Keegan et al. MRM, 73(2), 646–654. (2015).